What is it about?
Co-inhalation of roflumilast+fluticasone more significantly improved asthma than co-inhalation of formoterol+fluticasone in mice. Further studies are needed to help confirm the potential off-label add-on use of roflumilast in typical and atypical asthma and Asthma-COPD Overlap Syndrome
Featured Image
Read the Original
This page is a summary of: Therapeutic effects of co-inhaled roflumilast or formoterol and fluticasone on asthma-induced ultrastructural changes in murine airways, Tropical Journal of Pharmaceutical Research, January 2018, African Journals Online (AJOL),
DOI: 10.4314/tjpr.v16i11.10.
You can read the full text:
Contributors
The following have contributed to this page